Molecular Determinants of the Ratio of Inert to Infectious Virus Particles

Por Klasse, P.J.
Publicado no Prog Mol Biol Transl Sci (2014)

How to assess the binding strength of antibodies elicited by vaccination against HIV and other viruses

Por Klasse, P.J.
Publicado no Expert Rev Vaccines (2016)

Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives

Por Klasse, P. J.
Publicado no Adv Biol (2014)

Specificities and sensitivities of three systems for determination of antibodies to human immunodeficiency virus by electrophoretic immunoblotting.

Por Blomberg, J, Klasse, P J
Publicado em 1988

Quantification of immunoglobulin on electrophoretic immunoblot strips as a tool for human immunodeficiency virus serodiagnosis.

Por Blomberg, J, Klasse, P J
Publicado em 1988

Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1.

Por Klasse, P J, Moore, J P
Publicado em 1996

Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive...

Por Klasse, P J, Pipkorn, R, Blomberg, J
Publicado em 1988

Tropical spastic paraparesis associated with human T lymphotropic virus type I in an east African naturalised in Sweden.

Por Ryberg, B, Blomberg, J, Klasse, P J
Publicado em 1987

A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infec...

Por Moore, J P, Sattentau, Q J, Klasse, P J, Burkly, L C
Publicado em 1992

CD4-Chemokine Receptor Hybrids in Human Immunodeficiency Virus Type 1 Infection

Por Klasse, P. J., Rosenkilde, Mette M., Signoret, Nathalie, Pelchen-Matthews, Annegret, Schwartz, Thue W., Marsh, Mark
Publicado em 1999

The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope.

Por Wilson, C, Reitz, M S, Aldrich, K, Klasse, P J, Blomberg, J, Gallo, R C, Robert-Guroff, M
Publicado em 1990

Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1.

Por Binley, J M, Klasse, P J, Cao, Y, Jones, I, Markowitz, M, Ho, D D, Moore, J P
Publicado em 1997

Human T-Cell Leukemia Virus Type 1 Envelope Glycoprotein gp46 Interacts with Cell Surface Heparan Sulfate Proteoglycans

Por Piñon, Josefina D., Klasse, P. J., Jassal, Sushma R., Welson, Sandy, Weber, Jonathan, Brighty, David W., Sattentau, Quentin J.
Publicado em 2003

Protection of rhesus macaques from vaginal infection by vaginally delivered Maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor

Por Veazey, Ronald S., Ketas, Thomas J., Dufour, Jason, Moroney-Rasmussen, Terri, Green, Linda C., Klasse, P.J., Moore, John P.
Publicado em 2010

IgG Subclass Profiles in Infected HIV Type 1 Controllers and Chronic Progressors and in Uninfected Recipients of Env Vaccines

Por Banerjee, Kaustuv, Klasse, P.J., Sanders, Rogier W., Pereyra, Florencia, Michael, Elizabeth, Lu, Min, Walker, Bruce D., Moore, John P.
Publicado em 2010

Neutralization of Human Immunodeficiency Virus Type 1 by Antibody to gp120 Is Determined Primarily by Occupancy of Sites on the Virion Irrespective of Epitope Specificity

Por Parren, Paul W. H. I., Mondor, Isabelle, Naniche, Denise, Ditzel, Henrik J., Klasse, P. J., Burton, Dennis R., Sattentau, Quentin J.
Publicado em 1998

Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody.

Por Bugge, T H, Lindhardt, B O, Hansen, L L, Kusk, P, Hulgaard, E, Holmbäck, K, Klasse, P J, Zeuthen, J, Ulrich, K
Publicado em 1990

Pharmacokinetics of a CCR5 inhibitor in rhesus macaques following vaginal, rectal and oral application

Por Malcolm, R. Karl, Lowry, Deborah, Boyd, Peter, Geer, Leslie, Veazey, Ronald S., Goldman, Laurie, Klasse, P. J., Shattock, Robin J., Moore, John P.
Publicado em 2014

Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein.

Por Bron, R, Klasse, P J, Wilkinson, D, Clapham, P R, Pelchen-Matthews, A, Power, C, Wells, T N, Kim, J, Peiper, S C, Hoxie, J A, Marsh, M
Publicado em 1997

Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection

Por Dugast, Anne-Sophie, Stamatatos, Leonidas, Tonelli, Andrew, Suscovich, Todd J., Licht, Anna F., Mikell, Iliyana, Ackerman, Margaret E., Streeck, Hendrik, Klasse, P.J., Moore, John P., Alter, Galit
Publicado no Eur J Immunol (2014)